TI
ANGO icon

Trexquant Investment’s AngioDynamics ANGO Stock Holding History

Trexquant Investment’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$653K Sell
57,435
-205,644
-78% -$2.23M ﹤0.01% 1378
2025
Q4 		$3.38M Buy
263,079
+10,303
+4% +$127K 0.03% 772
2025
Q3 		$2.82M Sell
252,776
-105,596
-29% -$1.02M 0.03% 767
2025
Q2 		$3.56M Buy
358,372
+3,306
+0.9% +$32.4K 0.04% 660
2025
Q1 		$3.33M Buy
355,066
+273,295
+334% +$2.87M 0.04% 669
2024
Q4 		$749K Sell
81,771
-198,494
-71% -$1.46M 0.01% 1184
2024
Q3 		$2.18M Buy
280,265
+179,592
+178% +$1.3M 0.03% 777
2024
Q2 		$609K Buy
100,673
+88,401
+720% +$546K 0.01% 1179
2024
Q1 		$72K Sell
12,272
-128,209
-91% -$762K ﹤0.01% 1391
2023
Q4 		$1.1M Sell
140,481
-47,373
-25% -$329K 0.02% 789
2023
Q3 		$1.37M Buy
+187,854
New +$1.56M 0.03% 631
2023
Q2 		– Sell
-80,742
Closed -$835K – 1408
2023
Q1 		$835K Buy
+80,742
New +$1.03M 0.02% 806
2022
Q4 		– Sell
-11,429
Closed -$234K – 1349
2022
Q3 		$234K Buy
+11,429
New +$251K 0.01% 1127
2022
Q1 		– Sell
-10,383
Closed -$286K – 1324
2021
Q4 		$286K Sell
10,383
-7,097
-41% -$196K 0.02% 946
2021
Q3 		$453K Buy
17,480
+8,180
+88% +$219K 0.04% 575
2021
Q2 		$252K Sell
9,300
-15,073
-62% -$368K 0.02% 800
2021
Q1 		$570K Buy
24,373
+6,666
+38% +$135K 0.05% 462
2020
Q4 		$271K Sell
17,707
-1,869
-10% -$23.7K 0.03% 747
2020
Q3 		$236K Buy
+19,576
New +$186K 0.02% 1017
2018
Q2 		– Sell
-21,345
Closed -$368K – 880
2018
Q1 		$368K Buy
+21,345
New +$356K 0.03% 736
2017
Q4 		– Sell
-10,220
Closed -$175K – 1032
2017
Q3 		$175K Buy
+10,220
New +$172K 0.04% 666
2017
Q2 		– Sell
-20,635
Closed -$358K – 777
2017
Q1 		$358K Buy
+20,635
New +$345K 0.05% 676
2016
Q4 		– Sell
-10,158
Closed -$178K – 934
2016
Q3 		$178K Buy
+10,158
New +$165K 0.04% 654
2015
Q2 		– Sell
-29,800
Closed -$530K – 965
2015
Q1 		$530K Buy
+29,800
New +$554K 0.05% 659

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Trexquant Investment's ANGO Position: Q1 2026 in Review

Trexquant Investment reduced its AngioDynamics (ANGO) stake by 78% in Q1 2026, selling an estimated $2.23M and leaving 57,435 shares worth $653K. The position accounts for ﹤0.01% of the portfolio, ranked #1378.

Trexquant Investment first reported a position in ANGO in Q1 2015 and has held it in 24 quarters since. The position peaked at $3.56M in Q2 2025. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Trexquant Investment held 57,435 shares of AngioDynamics worth $653K as of Q1 2026.
  • Trexquant Investment sold 205,644 AngioDynamics shares in Q1 2026, an estimated $2.23M.
  • AngioDynamics made up ﹤0.01% of Trexquant Investment's portfolio in Q1 2026, its #1378 holding.
  • Trexquant Investment first reported a position in AngioDynamics in Q1 2015 and has held it in 24 quarters since.
  • Trexquant Investment's AngioDynamics position peaked at $3.56M in Q2 2025.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.